| Bioactivity | SARS-CoV-2 3CLpro-IN-15 (compound a) is a beta-nitrostyrene coronavirus SARS-CoV-2 inhibitor that targets the SARS-CoV-2 3CL protease (3CLpro). SARS-CoV-2 3CLpro-IN-15 inhibits viral replication and transcription and plays a key role in the discovery of anti-COVID-19 lead compounds[1]. |
| Target | IC50: 0.7297 μM (SARS-CoV-2 3CL protease) |
| Name | SARS-CoV-2 3CLpro-IN-15 |
| CAS | 3156-41-0 |
| Formula | C8H6N2O4 |
| Molar Mass | 194.14 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jia ZJ, et al. Synthesis, molecular docking, and binding Gibbs free energy calculation of β-nitrostyrene derivatives: Potential inhibitors of SARS-CoV-2 3CL protease. J Mol Struct. 2023 Jul 15;1284:135409.. |
SARS-CoV-2 3CLpro-IN-15
CAS: 3156-41-0 F: C8H6N2O4 W: 194.14
SARS-CoV-2 3CLpro-IN-15 (compound a) is a beta-nitrostyrene coronavirus SARS-CoV-2 inhibitor that targets the SARS-CoV-2
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.